<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(7)</volume><submitter>Funcke JB</submitter><pubmed_abstract>Upon obesity, adipose tissue is excessively expanded and characterized by pathologic processes like hypoxia, fibrosis, and inflammation. Death ligands belonging to the TNF superfamily such as TNF-α are important contributors to these derangements and exert a pronounced influence on the metabolic and cellular homeostasis of adipose tissue. Here, we sought to identify the effect of the death ligand TNF-related apoptosis-inducing ligand (TRAIL) on the adipose tissue precursor cell pool and therefore investigated its influence on preadipocyte proliferation. Treatment of human preadipocytes with TRAIL resulted in a time- and dose-dependent increase in proliferation (EC50 3.4 ng/ml) comparable to IGF-1. Although no apoptosis was observed, TRAIL triggered a rapid cleavage of caspase-8 and -3. Neither inhibition of caspase activity by zVAD.fmk (20 µM) nor ablation of caspase-8 expression by lentivirus-delivered small hairpin RNA (shRNA) abolished the proliferative response. TRAIL triggered a delayed and sustained activation of ERK1/2, leaving Akt, p38, JNK, and NF-κB unaffected. Importantly, inhibition of ERK1/2 activation by PD0325901 (300 nM) or AZD6244 (5 or 10 µM) completely abolished the proliferative response. We thus reveal a hitherto unknown function of TRAIL in regulating adipose tissue homeostasis by promoting the proliferation of tissue-resident precursor cells.</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pagination>3065-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4478800</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.</pubmed_title><pmcid>PMC4478800</pmcid><pubmed_authors>Zoller V</pubmed_authors><pubmed_authors>Debatin KM</pubmed_authors><pubmed_authors>Fischer-Posovszky P</pubmed_authors><pubmed_authors>Funcke JB</pubmed_authors><pubmed_authors>Wabitsch M</pubmed_authors><pubmed_authors>El Hay MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.</name><description>Upon obesity, adipose tissue is excessively expanded and characterized by pathologic processes like hypoxia, fibrosis, and inflammation. Death ligands belonging to the TNF superfamily such as TNF-α are important contributors to these derangements and exert a pronounced influence on the metabolic and cellular homeostasis of adipose tissue. Here, we sought to identify the effect of the death ligand TNF-related apoptosis-inducing ligand (TRAIL) on the adipose tissue precursor cell pool and therefore investigated its influence on preadipocyte proliferation. Treatment of human preadipocytes with TRAIL resulted in a time- and dose-dependent increase in proliferation (EC50 3.4 ng/ml) comparable to IGF-1. Although no apoptosis was observed, TRAIL triggered a rapid cleavage of caspase-8 and -3. Neither inhibition of caspase activity by zVAD.fmk (20 µM) nor ablation of caspase-8 expression by lentivirus-delivered small hairpin RNA (shRNA) abolished the proliferative response. TRAIL triggered a delayed and sustained activation of ERK1/2, leaving Akt, p38, JNK, and NF-κB unaffected. Importantly, inhibition of ERK1/2 activation by PD0325901 (300 nM) or AZD6244 (5 or 10 µM) completely abolished the proliferative response. We thus reveal a hitherto unknown function of TRAIL in regulating adipose tissue homeostasis by promoting the proliferation of tissue-resident precursor cells.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2024-11-14T06:24:39.755Z</modification><creation>2019-03-27T01:53:58Z</creation></dates><accession>S-EPMC4478800</accession><cross_references><pubmed>25857555</pubmed><doi>10.1096/fj.14-267278</doi></cross_references></HashMap>